This week we review Dr. Rory Spiegel's EMNerd blog post, A Case of Identity Part Two, on dual antiplatelet therapy for ACS and MI. 

Dual antiplatelet therapy, often aspirin + P2Y12 inhibitors, although commonly used, do not affect mortality and have questionable benefit but are associated with risks of bleeding.

Then, we delve into core content pearls on anticoagulation including aspirin, ibuprofen, and novel oral anticoagulants using Rosenalli  (Rosen's Emergency Medicine and Tintinalli's Emergency Medicine: A Comprehensive Review Guide) and Goldrank (10th ed) Chapter 60 and EMPractice October 2013 as a guide.  
As always, visit foamcast.org for show notes and the generously donated Rosh Review questions.
Thanks y'all!
-Jeremy Faust and Lauren Westafer